15
Participants
Start Date
October 3, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Pembrolizumab
Immunotherapy that works by helping the immune system to kill cancer cells by targeting and blocking a protein called PD-1 on the surface of certain immune cells called T-cells. Blocking PD-1 triggers the T-cells to find and kill cancer cells.
Carboplatin
A chemotherapy drug that contains the metal platinum. It stops or slows the growth of cancer cells and other rapidly growing cells by damaging their DNA.
Paclitaxel
A chemotherapeutic agent used as a treatment for various cancers; paclitaxel is a mitotic inhibitor.
RECRUITING
UPMC Hillman Cancer Center, Pittsburgh
Dan Zandberg
OTHER